A quadruple fluorescence quantitative PCR detection kit for detecting African swine fever

By designing a quadruple fluorescence quantitative PCR method with a combination of specific primers and fluorescent probes, the problem of difficulty in detecting African swine fever type I, type II wild strains and type II gene deletion strains in the prior art is solved, and rapid , efficient and accurate multi-gene detection, suitable for batch detection and avoid cross-reactions.

CN115852041BActive Publication Date: 2024-11-15BEIJING DABEINONG TECHNOLOGY GROUP CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210817649.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-12
Publication Date
2024-11-15
Estimated Expiration
2042-07-12

AI Technical Summary

Technical Problem

The prior art is difficult to detect and identify African swine fever type I, type II wild strains and type II gene deletion strains at the same time, and there is a lack of detection methods and kits for type I strains in China.

Method used

A set of specific primers and fluorescent probe combinations are designed for quadruple fluorescence quantitative PCR detection methods and kits. The combination of specific primers and fluorescent probes can simultaneously detect African swine fever type I and type II wild poison strains and Type II gene deletion strain uses FAM, VIC, Cy5 and TAMRA as fluorescent groups, and BHQ1, BHQ1, and BHQ3 as quenching groups to optimize the concentration ratio of primer and probe to ensure the relatively consistent amplification efficiency of the detection.

Benefits of technology

It realizes rapid, efficient and highly sensitive multi-gene detection, which can accurately distinguish different strains, avoid cross-reaction with common pig epidemic viruses, has good repetition and stability, and is suitable for batch detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003741504110000051
    Figure BDA0003741504110000051
  • Figure BDA0003741504110000061
    Figure BDA0003741504110000061
  • Figure BDA0003741504110000071
    Figure BDA0003741504110000071
Patent Text Reader

Abstract

The present invention relates to a quadruple fluorescent quantitative PCR detection kit for detecting African swine fever type I, type II wild strains and / or gene type II deletion strains, the kit comprising a group of specific primers and fluorescent probes for detecting African swine fever type I, type II wild strains and / or gene type II deletion strains, the nucleotide sequences of the specific primers are shown in SEQ ID NO.1, 2, 4, 5, 7, 8, 10, 11; the nucleotide sequences of the specific fluorescent probes are shown in SEQ ID NO.3, 6, 9, 12. The present invention designs a quadruple fluorescent quantitative PCR detection method, which can detect 4 genes at the same time, and the four pairs of primers and probes have relatively consistent amplification efficiency. Based on the characteristics of African swine fever epidemic strains in China, the present invention establishes a method for identifying African swine fever virus gene type I wild strains, gene type II wild strains and gene type II deletion strains.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biological detection technology, and in particular relates to a quadruple fluorescent quantitative PCR detection kit for detecting African swine fever type I, type II wild strains and / or gene type II deletion strains. Background Art

[0002] African swine fever (ASF) is a devastating hemorrhagic disease that primarily affects domestic pigs and wild boars, causing severe economic losses to the pig industry and threatening global food security. There is currently no commercial vaccine or effective treatment. African swine fever is listed as a notifiable disease by the World Organization for Animal Health and as a major transboundary animal disease by the Food and Agriculture Organization of the United Nations. ASF is caused by African swine fever virus (ASFV), which is the only DNA virus that replicates in and is transmitted by arthropods.

[0003] Vaccines are the most effective and economical way to prevent and control the spread of ASF, including inactivated vaccines, attenuated vaccines, subunit vaccines and gene vaccines, etc. Gene-deficient vaccines are the most likely ASF vaccines to succeed and are also the focus of research by major research institutions around the world. At present, there are many ASFV gene-deficient vaccines constructed in the world. The genes deleted in the vaccine strains mainly include MGF_360-9L, MGF_360-10L, MGF_360-11L, MGF_505-1R, MGF_360-12L, MGF_360-13L, MGF_360-14L, MGF_505-2R, MGF_505-3R, MGF_505-4R, MGF_505-6R, A224L, MGF_360-15R, A238L, TK, EP153R, CD2v, 9GL, NL-S, MGF_360-18R, NL, UK, etc. When constructing ASF gene-deficient vaccine strains, researchers usually insert fluorescent protein genes eGFP and mCherry, while ASFV wild strains do not carry eGFP and mCherry genes. At present, the ASFV gene-deficient seedlings in China are mainly constructed by Bu Zhigao's team from Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences and Hu Rongliang's team from Military Veterinary Research Institute, Military Medical Research Institute, Academy of Military Sciences, using domestically isolated epidemic strains as parents.

[0004] The genotype I strains of African swine fever were first isolated from clinical pig samples from pig farms in Shandong and Henan provinces. Both genotype I strains had no blood adsorption activity. Whole genome evolution analysis showed that these two strains were quite different from the genotype I virulent strains L60 and Benin 97, but were highly similar to the genotype I low-virulence strains NH / P68 and OURT88 / 3. The genotype I strains of African swine fever prevalent in China have a long incubation period, spread rapidly, and present mild and chronic infections. Infected pigs will only develop low levels of viremia, and early detection and diagnosis are more difficult than genotype II attenuated / weakened strains. Genotype I strains and genotype II attenuated / weakened strains may recombine. The emergence of genotype I African swine fever virus has brought more difficulties and greater challenges to China's eradication of African swine fever.

[0005] At present, the prevalent strains of African swine fever in China are relatively complex, including wild strains of genotype II, type II gene deletion strains and type I wild strains. Wild strains of genotype II clinically show decreased appetite, high fever, skin and mucosal bleeding, mainly acute onset, with a mortality rate of up to 100%, and can be accurately eliminated; type II gene deletion strains and type I wild strains have a prolonged incubation period, mild clinical manifestations, and joint swelling, hemorrhagic necrosis of the skin, low detoxification titers, intermittent detoxification, and are difficult to detect early and accurately eliminate. Pig farms may have single or mixed infections of different strains, and the corresponding African swine fever prevention and control measures and targeted elimination methods of pig farms are also very different. Therefore, it is extremely necessary to establish a rapid, efficient and sensitive detection method to distinguish wild strains of genotype II, type II gene deletion strains and type I wild strains.

[0006] At present, in the context of the research on gene-deficient vaccines for genotype II, the existing technology discloses real-time fluorescence quantitative PCR detection methods and kits for distinguishing wild strains and gene-deficient strains of genotype II African swine fever virus, but these are limited to one or two genes, and their clinical applications are limited. In addition, there are currently no detection methods and kits for genotype I strains in China. Therefore, it is urgent to establish a real-time fluorescence quantitative PCR method that is fast, accurate, and can simultaneously detect and identify multiple strains of African swine fever. Summary of the invention

[0007] In order to solve the above technical problems, the purpose of the present invention is to provide a quadruple quantitative fluorescent probe primer combination, detection method and kit that can be used to identify African swine fever genotype I wild strains, genotype II wild strains, and type II gene deletion strains.

[0008] The present invention provides a set of specific primers and fluorescent probe combinations for detecting African swine fever type I, type II wild strains and / or gene type II deletion strains, the nucleotide sequences of the specific primers are shown in SEQ ID NOs.1, 2, 4, 5, 7, 8, 10, and 11; the nucleotide sequences of the specific fluorescent probes are shown in SEQ ID NOs.3, 6, 9, and 12.

[0009] Furthermore, the 5' end of the probe is modified with different fluorescent groups, and the 3' end is modified with appropriate quenching groups.

[0010] Furthermore, the fluorescent groups are FAM, VIC, Cy5 and TAMRA, and the quenching groups are BHQ1, BHQ1, BHQ3 and BHQ2.

[0011] The present invention also provides the use of the primer and probe combination in preparing a kit for detecting African swine fever type I, type II wild strains and / or gene type II deletion strains.

[0012] The present invention also provides a quadruple fluorescent quantitative PCR detection kit for detecting African swine fever type I, type II wild strains and / or gene-deficient strains, wherein the kit comprises the primer and probe combination.

[0013] Furthermore, the kit also includes one or more of a probe method fluorescent quantitative PCR premix, a positive control and a negative control.

[0014] Furthermore, the positive control contains B646L, eGFP, mCherry and F778R genes, and the negative control is ddH2O.

[0015] Furthermore, the PCR amplification reaction system of the detection kit is: 10 μL of probe method fluorescent quantitative PCR premix, 0.4 μL of each 10 μM primer of claim 1, 0.2 μL of each 10 μM probe, 2 μL of nucleic acid template, and ddH2O to 20 μL.

[0016] Furthermore, the PCR amplification reaction conditions of the detection kit are: 37°C for 2 min; 95°C for 5 min; 95°C for 10 s, 60°C for 30 s, and 40 cycles.

[0017] The beneficial effects of the present invention compared to the prior art are:

[0018] The present invention designs a quadruple fluorescence quantitative PCR detection method, which can detect four genes at the same time, and the four pairs of primers and probes have relatively consistent amplification efficiency. Based on the characteristics of African swine fever epidemic strains in China, the present invention establishes a method for distinguishing African swine fever virus genotype I strains, genotype II strains and genotype II deletion strains.

[0019] The present invention designs appropriate primers and probes in the conservative sequence of the gene, and ensures that the four pairs of primers and probes maintain relatively consistent amplification efficiency by optimizing the primer concentration, the probe concentration and the ratio of the primer to the probe.

[0020] The African swine fever gene-deficient vaccine strains currently developed in China mainly lack the MGF gene and the EP402R gene. However, the MGF gene is relatively complex, and the primers and probes designed for the MGF gene cannot accurately detect the gene-deficient strains. Based on the fact that the gene-deficient vaccine strains constructed in China will insert the genes eGFP and mCherry, primers and probes targeting the eGFP and mCherry genes are designed to detect the eGFP and mCherry genes, thereby determining whether the sample is positive for the wild strain or the gene-deficient strain.

[0021] There are currently type I and type II strains in China, and the two strains differ in gene sequences such as F778R. Primers and probes targeting the F778R gene were designed to detect the F778R gene and identify whether it is a type I or type II strain.

[0022] In the present invention, primers and probes of different genes do not interfere with each other, and the detection sensitivity is high.

[0023] The invention has strong specificity and does not cause specific amplification with common swine epidemic virus strains.

[0024] The present invention has fast and high efficiency in detection, good repeatability and stability, and can be used for batch detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is a comparison of the amplified sequences of the F778R gene of genotype Ⅰ and Ⅱ strains (GⅠ: genotype 1; GⅡ: genotype 2; red bases: different bases).

[0026] Figure 2 is a synthetic sequence diagram of gene plasmids; wherein: A is a synthetic sequence diagram of B646L gene plasmids; B is a synthetic sequence diagram of eGFP gene plasmids; C is a synthetic sequence diagram of mCherry gene plasmids; and D is a synthetic sequence diagram of F778R gene plasmids.

[0027] Figure 3 is a judgment diagram of the detection results of different strains; among them: A is the amplification curve diagram of the genotype I wild strain; B is the amplification curve diagram of the genotype II wild strain; C~E are the amplification curve diagrams of the type II gene deletion strain; 1a~1d are the positive control FAM, VIC, Cy5, and TARMA channel amplification curves; 2a~2d are the sample FAM, VIC, Cy5, and TARMA channel amplification curves; 3a~3d are the negative control amplification curves.

[0028] Figure 4Figure 1 is a specific test amplification curve of quadruple real-time fluorescence quantitative PCR; 1a to 1d are the amplification curves of FAM, VIC, Cy5, and TARMA channels of type II gene deletion strains; 2a to 2d are the amplification curves of FAM, VIC, Cy5, and TARMA channels of genotype I wild strains; 3 to 10 are the amplification curves of PRRSV, CSFV, PRV, PCV2, PCV3, PEDV, TGEV, and negative control, respectively.

[0029] FIG5 is a graph showing the sensitivity detection results of quadruple real-time fluorescence quantitative PCR; wherein: A is the amplification curve of the B646L gene; B is the amplification curve of the eGFP gene; C is the amplification curve of the mCherry gene; D is the amplification curve of the F778R gene; a~g are 10 7 ~10 1 copies / μL; h: negative control

[0030] Figure 6 is a diagram showing the results of constructing a standard curve for quadruple real-time fluorescence quantitative PCR; wherein: A is a standard curve diagram for the B646L gene; B is a standard curve diagram for the eGFP gene; C is a standard curve diagram for the mCherry gene; and D is a standard curve diagram for the F778R gene.

[0031] Figure 7 is an amplification curve diagram of clinical samples detected by the quadruple real-time fluorescence quantitative PCR detection method; wherein: A is a genotype II wild strain; B is a type II gene deletion strain; C is a genotype I wild strain; 1a~1d are amplification curves of the positive control; 2a~2d are amplification curves of clinical samples; 3a~3d are amplification curves of the negative control.

[0032] Figure 8 It is the phylogenetic tree of positive samples of type I wild strains and type II wild strains; among them: 1 and 2 are type I wild strains identified by this method; 3 and 4 are type II wild strains identified by this method; GⅠMZ945536 is a genotype I isolate; GⅡMK333180 is a genotype II isolate.

[0033] Fig. 9 1 and 2 are type II wild strains identified by this method; 3 and 4 are type II gene deletion strains identified by this method; 5 is mCherry positive control; 7 is eGFP positive control; 6 and 8 are negative controls. DETAILED DESCRIPTION

[0034] The following examples are used to illustrate the present invention but are not intended to limit the scope of the present invention.

[0035] Example 1

[0036] 1. Design of specific primers and probes

[0037] At present, the main ASFV genotype I and II strains are prevalent in China, and there are differences in the F778R gene sequences of the two strains. Compare the F778R genes of the genotype I and II strains prevalent in China and abroad, and design specific primers and probes in the different and conservative regions. The comparison results of the designed primer amplification sequence in the two genotype strains are as follows Figure 1 At the same time, according to the gene sequences of B646L (MK333180), eGFP (MN623123), and mCherry (MN781140) published by GenBank, specific primers and probes were designed in their conserved regions. The specific sequences are shown in Table 1.

[0038] When constructing ASF gene-deficient vaccine strains, fluorescent protein genes eGFP and mCherry are usually inserted, but wild ASFV does not carry eGFP and mCherry genes. Type II wild strains and type II gene-deficient strains can be identified by detecting the two genes eGFP and mCherry. Genotype I and type II strains differ in the F778R gene sequence. Specific primers and probes designed in the different and conservative regions can distinguish between genotype I and type II strains.

[0039] Table 1 Primer and probe sequences

[0040]

[0041] 2. Preparation of Plasmid Standards

[0042] According to the sequences of ASFV Chinese isolates (MK333180 and MZ945536) and eGFP and mCherry gene sequences (MN623123 and MN781140) in GenBank, the gene sequences B646L, eGFP, mCherry and F778R were synthesized respectively (see Figure 2 for specific sequences), cloned into the pUC57 vector, transformed into bacterial competent cells DH5α, and the plasmids were extracted. After sequencing verification, they were used as plasmid standards for multiplex fluorescence quantitative PCR.

[0043] 3. Fluorescence quantitative PCR detection method

[0044] (1) PCR amplification reaction

[0045] The nucleic acid extracted from samples such as throat swabs was used as a template, the plasmid standard was used as a positive control, and ddH2O was used as a negative control; Table 2 shows the amplification reaction system: 10 μL of PCR premix, 0.4 μL of each primer, 0.2 μL of each probe, 2 μL of nucleic acid template, and ddH2O was added to 20 μL; Table 3 shows the amplification reaction conditions for quadruple fluorescence quantitative PCR amplification reaction.

[0046] Table 2 Amplification reaction system

[0047] Composition volume 2×AceQ Universal U+Probe Master Mix V2 10μL Primer 1 (10 μM) 0.4μL Primer 2 (10 μM) 0.4μL TaqMan Probe (10μM) 0.2μL Template DNA 2μL <![CDATA[ddH2O]]> Up to 20μL

[0048] Table 3 Amplification reaction conditions

[0049]

[0050] Note: Fluorescence signals were collected during amplification at 60°C.

[0051] (2) Result determination

[0052] The positive control has four channels with Ct values ​​of <35 and a specific amplification curve, while the negative control has no Ct value and no specific amplification curve. Only when both are established can the experimental results be determined to be established. The test results are shown in Figure 3 and Table 4.

[0053] When there are signals and specific amplification curves in the FAM and TARMA fluorescence signal channels, but no signals or amplification curves in the VIC and Cy5 fluorescence signal channels, it is determined to be a type I wild-type strain;

[0054] When the FAM fluorescence signal channel has a signal and a specific amplification curve, but the VIC, Cy5, and TARMA fluorescence signal channels have no signal or amplification curve, it is determined to be a type II wild-type strain;

[0055] When there is a signal and a specific amplification curve in the FAM fluorescence signal channel, and there is a signal and a specific amplification curve in either or both of the VIC and Cy5 fluorescence signal channels, it is determined to be a type II gene deletion strain;

[0056] When there is no signal or amplification curve in the FAM, VIC, Cy5 and TARMA fluorescence signal channels, it is judged as negative.

[0057] Table 4 Test result judgment table

[0058]

[0059] Note: Only the presence of FAM signal can indicate that the African swine fever virus nucleic acid is positive. If there is no FAM signal but there are other signals, it means that the experiment is invalid and needs to be retested.

[0060] 4. Specificity test

[0061] Fluorescence quantitative PCR was performed using the positive nucleic acids of type II gene-deleted strains, type I wild strains, and common viruses in pig farms, such as porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus (CSFV), pseudorabies virus (PRV), porcine circovirus type 2 (PCV2), porcine circovirus type 3 (PCV3), porcine epidemic diarrhea virus (PEDV), and porcine transmissible gastroenteritis virus (TGEV), as templates using the above-mentioned reaction system and procedures.

[0062] The results are as follows Figure 4 As shown, the results of PRRSV, CSFV, PRV, PCV2, PCV3, PEDV, TGEV detection and negative control detection were all negative, indicating that the method has good specificity and no cross-reaction with common swine viral disease pathogens, and can be used for clinical detection.

[0063] 5. Sensitivity test

[0064] The standard plasmid was diluted 10-fold to a concentration of 10 7 ~10 1 The above reaction system and procedure were used to perform fluorescence quantitative PCR detection with the diluted plasmid as a template, and the standard curve was analyzed at the same time.

[0065] The results are shown in Figure 5. The minimum copy number of the positive standard plasmid that can be detected by quadruple fluorescence quantitative PCR can reach 10 copies, indicating that this method has a high sensitivity. The results are shown in Figure 6. Within the dilution concentration range, the template amount and the Ct value show a good linear relationship, and the correlation coefficient R 2 All are greater than 0.99.

[0066] 6. Repeatability test

[0067] The standard plasmid was diluted 10-fold to a concentration of 10 7 ~10 1 The above reaction system and procedure were used to perform fluorescence quantitative PCR detection with the diluted plasmid as template, and 3 replicates were set for each gradient.

[0068] The results showed that the repeatability of each gradient was very good, and the coefficient of variation (CV value) was less than 10%, indicating that the method has good repeatability.

[0069] 7. Clinical sample testing

[0070] The above method was used to test 935 clinical samples from pig farms that were confirmed to be diseased by a third party. Each sample was divided into two and sent to the third party for testing at the same time.

[0071] According to the judgment criteria, the results are shown in Table 5 and Figure 7. This method detected a total of 13 positive samples, and the third party detected 13 positive samples. The positive test results of this method and the third-party testing agency were the same. From the 13 positive samples, 2 positive samples of type I wild strains, type II wild strains and type II gene-deficient strains were selected for verification. The verification of type I wild strains and type II wild strains used the universal typing primers reported in the literature to amplify the B646L gene. After obtaining the gene sequence, it was compared and analyzed with other strains. The results are shown as follows Figure 8The verification of type II wild strain and type II gene deletion strain was carried out by amplifying the full length of eGFP and mCherry genes for comparison. The primer sequences and amplification lengths are shown in Table 6. The reaction parameters were: (94°C, 5 min) + [(94°C, 30 s) + (60°C, 30 s) + (72°C, 1 min)] × 32 + (72°C, 5 min). The results are shown in Fig. 9 The above verification shows that the strain type detected by this method is consistent with the sequence comparison result, indicating that this method can achieve the purpose of sensitive, rapid and accurate detection of different African swine fever virus strains.

[0072] Table 5 Clinical sample test results

[0073] Strain type This method Third-party testing Sequencing alignment ASFV negative 922 922 / ASFV positive 13 13 / Among them: Type I wild strain 2 / 2 Type II wild strain 8 / 2 Type II gene deletion strain 3 / 2

[0074] Table 6 Primer and probe sequences

[0075]

Claims

1. A set of specific primers and fluorescent probe combinations for simultaneously detecting African swine fever type I, type II wild strains and gene type II deletion strains, characterized in that: The nucleotide sequences of the specific primers are shown in SEQ ID NOs. 1, 2, 4, 5, 7, 8, 10 and 11; the nucleotide sequences of the specific fluorescent probes are shown in SEQ ID NOs. 3, 6, 9 and 12.

2. The specific primer and fluorescent probe combination according to claim 1, characterized in that: The 5' ends of the probes are modified with different fluorescent groups, and the 3' ends are modified with corresponding quenching groups.

3. The specific primer and fluorescent probe combination according to claim 2, characterized in that: The fluorescent groups are FAM, VIC, Cy5 and TAMRA, and the quenching groups are BHQ1, BHQ1, BHQ3 and BHQ2.

4. Use of the specific primer and fluorescent probe combination described in claim 1 in the preparation of a kit for detecting African swine fever type I, type II wild strains and gene type II deletion strains.

5. A quadruple fluorescence quantitative PCR detection kit for simultaneously detecting African swine fever type I, type II wild strains and gene type II deletion strains, characterized in that: The kit comprises the primer and probe combination of claim 1.

6. The kit according to claim 5, characterized in that The kit also includes one or more of a probe method fluorescent quantitative PCR premix, a positive control and a negative control.

7. The kit according to claim 6, characterized in that The positive control contained B646L, eGFP, mCherry and F778R genes, and the negative control was ddH2O.

8. The kit according to any one of claims 5 to 7, characterized in that: The PCR amplification reaction system of the detection kit is: 10 μL of probe method fluorescent quantitative PCR premix, 0.4 μL of each 10 μM primer of claim 1, 0.2 μL of each 10 μM probe, 2 μL of nucleic acid template, and ddH2O to 20 μL.

9. The kit according to any one of claims 5 to 7, characterized in that: The PCR amplification reaction conditions of the detection kit are: 37°C for 2 min; 95°C for 5 min; 95°C for 10 s, 60°C for 30 s, and 40 cycles.